A detailed history of Fmr LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Fmr LLC holds 16,944 shares of AADI stock, worth $33,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,944
Previous 4,009 322.65%
Holding current value
$33,718
Previous $9,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.46 - $2.31 $18,885 - $29,879
12,935 Added 322.65%
16,944 $24,000
Q1 2024

May 13, 2024

BUY
$1.59 - $2.44 $2,332 - $3,579
1,467 Added 57.71%
4,009 $9,000
Q4 2023

Feb 13, 2024

BUY
$1.97 - $5.41 $636 - $1,747
323 Added 14.56%
2,542 $5,000
Q3 2023

Nov 13, 2023

BUY
$4.84 - $7.13 $6,853 - $10,096
1,416 Added 176.34%
2,219 $10,000
Q2 2023

Aug 11, 2023

SELL
$6.84 - $8.56 $22,715 - $28,427
-3,321 Reduced 80.53%
803 $5,000
Q1 2023

May 11, 2023

BUY
$6.85 - $13.0 $26,386 - $50,076
3,852 Added 1416.18%
4,124 $29,000
Q4 2022

Feb 13, 2023

SELL
$11.99 - $14.5 $26,665 - $32,248
-2,224 Reduced 89.1%
272 $3,000
Q3 2022

Nov 10, 2022

BUY
$12.03 - $14.22 $29,317 - $34,654
2,437 Added 4130.51%
2,496 $35,000
Q2 2022

Aug 12, 2022

BUY
$11.57 - $17.92 $682 - $1,057
59 New
59 $1,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $41.8M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.